SL-01

• Target:

  Others|||DNA/RNA Synthesis|||Autophagy|||Apoptosis|||Nucleoside Antimetabolite/Analog

• Related Pathways:

  Cell Cycle/Checkpoint|||Others|||Apoptosis|||Autophagy|||DNA Damage/DNA Repair

• Bioactivity:

  SL-01 is an oral derivative of gemcitabine. SL-01 inhibited human breast cancer growth through the induction of apoptosis. SL-01 inhibited human cancer growth more potently than gemcitabine.

• Smiles:

  ClCC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1

• Molecular Formula:

  C18H18ClNO3

• Molecular Weight:

  331.79

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  26049-94-5